Regeneron Pharmaceuticals, Inc. (LON: 0R2M)
London
· Delayed Price · Currency is GBP · Price in USD 687.82
+2.15 (0.31%)
Jan 22, 2025, 7:07 PM BST
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of 59.41 billion as of January 23, 2025. Its market cap has decreased by -22.08% in one year.
Market Cap
59.41B
Enterprise Value
46.75B
Revenue
10.33B
Ranking
n/a
PE Ratio
17.11
Stock Price
687.82
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 96.12M to 59.41B, an increase of 61,704.30%. That is a compound annual growth rate of 21.84%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.37B |
| GSK plc | 55.25B |
| Haleon | 33.81B |
| Smith & Nephew | 9.04B |
| ConvaTec Group | 4.94B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 1.99B |
| Oxford Nanopore Technologies | 1.42B |